Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06441422 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction Training for People With Disabilities
A NA study of Weakness, Muscle, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06441422: Recruiting NA study of Weakness, Muscle, sponsored by Medical College of Wisconsin.
NCT06441422 is a NA study of Weakness, Muscle that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 24 participants, below the 786-participant average among 4 other Weakness, Muscle trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06441422, a NA study of Weakness, Muscle, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
A large portion of the American population live with disabilities. People with disabilities can find it difficult to perform standard exercise routines. Regular exercise is necessary to be healthy, especially as people age. Lack of exercise can lead to secondary health concerns, like loss of muscle mass, diabetes, heart attack or stroke, to name a few. For exercise to be most beneficial, a certain degree of intensity must be achieved. Low load blood flow restriction training may be able to mimic the intensity of beneficial exercise without actually exercising hard. It may be a good option for people with disabilities who find it difficult to exercise.
Primary Outcome
This outcome will measure the efficacy of low load blood flow restriction training (LLBFR) on muscle strength. The difference in muscle strength as measured by change in 1-repetition maximum weight in pounds will be compared in individuals training with LLBFR on their arm extensors and individuals training with low load resistance training (LLRT) on their arm extensors compared to their baseline.
Conditions Studied
Interventions
- OTHER Blood flow restriction training
- OTHER No blood flow restriction training
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-12-12 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT06441422 shows while recruiting
NCT06441422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 786-participant average among 4 other Weakness, Muscle trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Weakness, Muscle appearing as the primary indexed condition, and to 2 interventions - of which Blood flow restriction training is the first listed.
NCT06441422 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06441422 about?
NCT06441422 is a clinical study titled "Blood Flow Restriction Training for People With Disabilities". A large portion of the American population live with disabilities. People with disabilities can find it difficult to perform standard exercise routines. Regular exercise is necessary to be healthy, especially as people age. Lack of exercise can lead to secondary health concerns, like loss of muscle ...
What is the current status of trial NCT06441422?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-12-12. Estimated completion is 2027-12-31.
What conditions does trial NCT06441422 study?
This clinical trial studies the following conditions: Weakness, Muscle.
What interventions are being tested in trial NCT06441422?
The interventions under investigation include: Blood flow restriction training (OTHER), No blood flow restriction training (OTHER).
Who is sponsoring clinical trial NCT06441422?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06441422 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weakness, Muscle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
A Study of Healthy Microbiome, Healthy Mind
RECRUITING · NA
-
Precision Medicine and Physical Function
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI